Ethics, Info, Tech: Contested Voices, Values, Spaces

The Ebook version of my Bloomsbury book "Ethics, Information, and Technology" will be published on December 11, 2025 and the Hardback, Cloth, and Paperback versions will be available on January 8, 2026. Preorders are available via Amazon and this Bloomsbury webpage: https://www.bloomsbury.com/us/ethics-information-and-technology-9781440856662/

Showing posts with label pharmaceutical companies. Show all posts

Sunday, March 19, 2017

One Way To Force Down Drug Prices: Have The U.S. Exercise Its Patent Rights; NPR, March 16, 2017

›

Alison Kodjak, NPR; One Way To Force Down Drug Prices: Have The U.S. Exercise Its Patent Rights "... Trump already has a weapon ...

Wednesday, November 30, 2016

Summer Project Turns Into Leukemia Testing Breakthrough; New York Times, 11/28/16

›

Donald G. McNeil Jr., New York Times; Summer Project Turns Into Leukemia Testing Breakthrough : 'Gleevec, which made almost $5 billion ...

Saturday, October 17, 2015

Why do drug companies charge so much? Because they can.; Washington Post, 9/25/15

›

Marcia Angell, Washington Post; Why do drug companies charge so much? Because they can. : "Drugmakers are now getting some pushback f...

›

Home

View web version

About Me

Kip Currier, PhD, JD: Assistant Professor, University of Pittsburgh School of Computing and Information. Education: PhD, University of Pittsburgh School of Information Sciences (2007); Juris Doctor (JD), University of Pittsburgh School of Law; Master of Library and Information Science (MLIS), University of Pittsburgh School of Information Sciences. Member of American Bar Association (ABA), ABA IP Law Section, ABA Science & Technology Section

View my complete profile